CENTIPAINE FOR PAIN CONTROL- lidocaine 4%, menthol 1% patch

Land: Vereinigte Staaten

Sprache: Englisch

Quelle: NLM (National Library of Medicine)

Wirkstoff:

LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987), MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (MENTHOL, UNSPECIFIED FORM - UNII:L7T10EIP3A)

Verfügbar ab:

Whitestone Products LLC

Verabreichungsweg:

TOPICAL

Verschreibungstyp:

OTC DRUG

Anwendungsgebiete:

Purpose Topical Analgesic Uses For the temporary relief of pain. Do not use - in large quantities, particularly over raw surfaces, or blistered areas.

Berechtigungsstatus:

OTC monograph not final

Fachinformation

CENTIPAINE FOR PAIN CONTROL- LIDOCAINE 4%, MENTHOL 1% PATCH
WHITESTONE PRODUCTS LLC
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may_
_be marketed if they comply with applicable regulations and policies.
FDA has not_
_evaluated whether this product complies._
----------
CENTIPAINE FOR PAIN CONTROL
ACTIVE INGREDIENTS
Lidocaine 4%
Menthol 1%
PURPOSE
Topical Analgesic
USES
For the temporary relief of pain.
WARNINGS
FOR EXTERNAL USE ONLY not intended for ingestion.
DO NOT USE
in large quantities, particularly over raw surfaces, or blistered
areas.
WHEN USING THIS PRODUCT
Avoid contact with the eyes.
STOP USE AND ASK DOCTOR IF
condition worsens, or if symtoms persist for more than 7 days or clear
up and occur
again within a few days.
KEEP OUT OF REACH OF CHILDREN.
If swallowed, get medical help, or contact a Poison Control Central
right away.
IF PREGNANT OR BREAST-FEEDING, ask a health professional before use.
DIRECTIONS
Adults and children 2 years of age and older: Apply to affected area
not more than 3
to 4 times a daily.
Children under 2 years of age: consult a doctor.
OTHER INFORMATION
Store at 20-25
C (68-77
F) and protect from moisture.
INACTIVE INGREDIENTS
polyacrylamide, vinol, sodium polyacrylate; acrylate polymerization,
purified water.
QUESTIONS?
o
o
[phone]
CENTIPAINE FOR PAIN CONTROL
lidocaine 4%, menthol 1% patch
PRODUCT INFORMATION
PRODUCT TYPE
HUMAN OTC DRUG
ITEM CODE (SOURCE)
NDC:81902-120
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH STRENGTH
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)
LIDOCAINE
4 g
in 100 g
MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (MENTHOL, UNSPECIFIED
FORM - UNII:L7T10EIP3A)
MENTHOL, UNSPECIFIED
FORM
1 g
in 100 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRENGTH
POLYACRYLAMIDE (10000 MW) (UNII: E2KR9C9V2I)
ETHENYL (UNII: PQ2K3G3591)
ACRYLATES CROSSPOLYMER-6 (UNII: 4GXD0Q3OS3)
SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)
WATER (UNII: 059QF0KO0R)
PACKAGING
#
ITEM CODE
PA